Overview

Comparison of Insulin Therapy in Treating Post-Transplant Diabetes

Status:
Terminated
Trial end date:
2015-03-01
Target enrollment:
Participant gender:
Summary
To determine if the use of insulin isophane results in improved control of blood sugars compared to the use of insulin glargine in new onset diabetes after kidney, lung, or heart transplantation (NODAT).
Phase:
Phase 4
Details
Lead Sponsor:
Inova Health Care Services
Treatments:
Insulin
Insulin Glargine
Insulin, Globin Zinc
Insulin, Isophane
Isophane insulin, beef
Isophane Insulin, Human